ITEM 2.05. COSTS ASSOCIATED WITH EXIT OR DISPOSAL ACTIVITIES.



On November 17, 2020, Boston Scientific Corporation (the "Company") announced a
global, voluntary recall of all unused inventory of its LOTUS Edge™ Aortic Valve
System, and its decision to retire the entire LOTUS platform immediately.

The Company estimates the decision will result in total pre-tax charges of
approximately $225 million to $300 million, which includes $50 million to $100
million of estimated charges expected to result in future cash outlays. The
following table provides a summary of the Company's estimate of costs associated
with the product discontinuation, the vast majority of which are expected to be
recorded in the fourth quarter of 2020:

                     Type of Cost                       Total Estimated

Amount Expected to be Incurred



Working capital:
Inventory write-offs and other                                   $100 million to $150 million
Intangible asset impairment charges:                                     $10 million
Restructuring charges:
Exit costs (1)                                                    $45 million to $60 million
Restructuring-related expenses (2):                               $70 million to $80 million
                                                                 $225 million to $300 million



(1) Comprised of termination benefits, contractual cancellations and certain
other exit costs.
(2) Comprised of other costs directly related to the product discontinuation,
including fixed asset write-offs and plant decommissioning costs.

ITEM 8.01. OTHER EVENTS.

The Company issued a press release on November 17, 2020, announcing its decision. A copy of the press release is included as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.



(d) Exhibits


Exhibit No.             Description
  99.1                    Press Release issued by Boston Scientific

Corporation, dated November 17,


                        2020.
104                     Cover Page Interactive Data File (embedded within the Inline XBRL document).






--------------------------------------------------------------------------------

Cautionary Statement Regarding Forward-Looking Statements



This Current Report on Form 8-K contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934. Forward-looking statements may be identified by
words like "anticipate," "expect," "project," "believe," "plan," "estimate,"
"intend" and similar words. These forward-looking statements are based on our
beliefs, assumptions and estimates using information available to us at the time
and are not intended to be guarantees of future events or performance. These
forward-looking statements include, among other things, statements about the
impact of the decision, including future financial results, our plans,
objectives, expectations and intentions, the expected timing for recording
associated charges and other statements that are not historical facts. If our
underlying assumptions turn out to be incorrect, or if certain risks or
uncertainties materialize, actual results could vary materially from the
expectations and projections expressed or implied by our forward-looking
statements. These factors, in some cases, have affected and in the future
(together with other factors) could affect our ability to implement our business
strategy and may cause actual results to differ materially from those
contemplated by the statements expressed in this Current Report on Form 8-K. As
a result, readers are cautioned not to place undue reliance on any of our
forward-looking statements.

Factors that may cause such differences include, among other things: future
economic, political, competitive, reimbursement and regulatory conditions; new
product introductions; demographic trends; intellectual property; litigation;
financial market conditions; and future business decisions made by us and our
competitors. All of these factors are difficult or impossible to predict
accurately and many of them are beyond our control. For a further list and
description of these and other important risks and uncertainties that may affect
our future operations, see Part I, Item 1A - Risk Factors in our most recent
Annual Report on Form 10-K filed with the Securities and Exchange Commission,
which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on
Form 10-Q we have filed or will file hereafter. We disclaim any intention or
obligation to publicly update or revise any forward-looking statements to
reflect any change in our expectations or in events, conditions, or
circumstances on which those expectations may be based, or that may affect the
likelihood that actual results will differ from those contained in the
forward-looking statements. This cautionary statement is applicable to all
forward-looking statements contained in this document.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses